Capital International Sarl Takes Position in Marsh & McLennan Companies, Inc. $MRSH

Capital International Sarl purchased a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 58,099 shares of the financial services provider’s stock, valued at approximately $10,779,000.

Other hedge funds have also modified their holdings of the company. Numerai GP LLC raised its position in shares of Marsh & McLennan Companies by 966.2% in the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock valued at $7,501,000 after acquiring an additional 33,729 shares during the period. Swiss Life Asset Management Ltd raised its position in shares of Marsh & McLennan Companies by 9.5% in the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after acquiring an additional 11,648 shares during the period. Rockland Trust Co. raised its position in shares of Marsh & McLennan Companies by 801.6% in the 3rd quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock valued at $2,433,000 after acquiring an additional 10,734 shares during the period. Barclays PLC raised its position in shares of Marsh & McLennan Companies by 41.7% in the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock valued at $443,844,000 after acquiring an additional 647,987 shares during the period. Finally, Sarasin & Partners LLP raised its position in shares of Marsh & McLennan Companies by 0.9% in the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock valued at $173,411,000 after acquiring an additional 8,283 shares during the period. 87.99% of the stock is currently owned by institutional investors and hedge funds.

Marsh & McLennan Companies Price Performance

NYSE MRSH opened at $165.37 on Friday. The company has a market cap of $79.89 billion, a P/E ratio of 20.67, a price-to-earnings-growth ratio of 2.41 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 52-week low of $156.60 and a 52-week high of $231.36. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The company had revenue of $7.30 billion for the quarter. The company’s revenue was up 7.6% compared to the same quarter last year. Equities analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on MRSH shares. Morgan Stanley cut their price target on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating on the stock in a research report on Monday, April 6th. Mizuho lowered their target price on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research note on Monday, April 13th. Raymond James Financial raised Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 target price for the company in a research note on Tuesday, February 17th. Wells Fargo & Company lowered their target price on Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research note on Thursday, April 9th. Finally, Citigroup raised Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 target price for the company in a research note on Wednesday, May 6th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $203.56.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.